These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3058874)

  • 1. Quality of life in stage II breast cancer: an instrument for clinical trials.
    Levine MN; Guyatt GH; Gent M; De Pauw S; Goodyear MD; Hryniuk WM; Arnold A; Findlay B; Skillings JR; Bramwell VH
    J Clin Oncol; 1988 Dec; 6(12):1798-810. PubMed ID: 3058874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG).
    Fairclough DL; Fetting JH; Cella D; Wonson W; Moinpour CM
    Qual Life Res; 1999 Dec; 8(8):723-31. PubMed ID: 10855346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
    Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
    Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.
    Fetting JH; Gray R; Fairclough DL; Smith TJ; Margolin KA; Citron ML; Grove-Conrad M; Cella D; Pandya K; Robert N; Henderson IC; Osborne CK; Abeloff MD
    J Clin Oncol; 1998 Jul; 16(7):2382-91. PubMed ID: 9667255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
    Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
    Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness and validity in health status measurement: a clarification.
    Guyatt GH; Deyo RA; Charlson M; Levine MN; Mitchell A
    J Clin Epidemiol; 1989; 42(5):403-8. PubMed ID: 2659745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer.
    Yates P; Aranda S; Hargraves M; Mirolo B; Clavarino A; McLachlan S; Skerman H
    J Clin Oncol; 2005 Sep; 23(25):6027-36. PubMed ID: 16135471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
    Navari RM; Brenner MC; Wilson MN
    Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
    Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
    JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for metastatic breast cancer.
    Mayer EL; Burstein HJ
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):257-72. PubMed ID: 17512448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Effects of Pranic Meditation on the Mental Health and Quality of Life of Breast Cancer Survivors.
    Castellar JI; Fernandes CA; Tosta CE
    Integr Cancer Ther; 2014 Jul; 13(4):341-50. PubMed ID: 24906909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.
    Boyle FM; Smith IE; O'Shaughnessy J; Ejlertsen B; Buzdar AU; Fumoleau P; Gradishar W; Martin M; Moy B; Piccart-Gebhart M; Pritchard KI; Lindquist D; Amonkar M; Huang Y; Rappold E; Williams LS; Wang-Silvanto J; Kaneko T; Finkelstein DM; Goss PE;
    Eur J Cancer; 2015 Apr; 51(6):685-96. PubMed ID: 25752740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
    Richardson LC; Wang W; Hartzema AG; Wagner S
    Breast J; 2007; 13(6):581-7. PubMed ID: 17983400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles.
    Genre D; Protière C; Macquart-Moulin G; Gravis G; Camerlo J; Alzieu C; Maraninchi D; Moatti JP; Viens P
    Support Care Cancer; 2002 Apr; 10(3):222-30. PubMed ID: 11904787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial.
    Purmonen TT; Pänkäläinen E; Turunen JH; Asseburg C; Martikainen JA
    Acta Oncol; 2011 Apr; 50(3):344-52. PubMed ID: 21299447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
    Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB
    Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.